Share on LinkedInShare on LinkedIn

ARTICLE · 08 DECEMBER 2021

Patent Litigation Trends: The Future Of Biologics?

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

Biologics and biosimilars innovation and production is on the rise. But how is this affecting intellectual property (IP) trends and patent litigation?

GlobalIntellectual Property

Biologics and biosimilars innovation and production is on the rise. But how is this affecting intellectual property (IP) trends and patent litigation?

As the biologics market continues to expand, patent litigation is also increasing. Our report 'Patent litigation trends: the future of biologics and next generation therapies' examines what we're likely to see in the next few years in this industry and how litigators can prepare for the increase of innovation in biosimilars and next generation therapies.

Our Life Sciences team and global IP lawyers teamed up with Life Sciences IP Review to survey those at the forefront of the biologics and next generation therapies industry to better understand the emerging trends in IP law. The findings share companies' own experiences with these complex molecules, the issues they present and the pattern of litigation arising.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from